These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 10871856)

  • 1. Cross-talk between the proto-oncogenes Met and Ron.
    Follenzi A; Bakovic S; Gual P; Stella MC; Longati P; Comoglio PM
    Oncogene; 2000 Jun; 19(27):3041-9. PubMed ID: 10871856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential.
    Williams TA; Longati P; Pugliese L; Gual P; Bardelli A; Michieli P
    J Cell Physiol; 1999 Dec; 181(3):507-14. PubMed ID: 10528237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ron kinase transphosphorylation sustains MET oncogene addiction.
    Benvenuti S; Lazzari L; Arnesano A; Li Chiavi G; Gentile A; Comoglio PM
    Cancer Res; 2011 Mar; 71(5):1945-55. PubMed ID: 21212418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway.
    Danilkovitch-Miagkova A; Miagkov A; Skeel A; Nakaigawa N; Zbar B; Leonard EJ
    Mol Cell Biol; 2001 Sep; 21(17):5857-68. PubMed ID: 11486025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STK/RON receptor tyrosine kinase mediates both apoptotic and growth signals via the multifunctional docking site conserved among the HGF receptor family.
    Iwama A; Yamaguchi N; Suda T
    EMBO J; 1996 Nov; 15(21):5866-75. PubMed ID: 8918464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasiveness.
    Maggiora P; Lorenzato A; Fracchioli S; Costa B; Castagnaro M; Arisio R; Katsaros D; Massobrio M; Comoglio PM; Flavia Di Renzo M
    Exp Cell Res; 2003 Aug; 288(2):382-9. PubMed ID: 12915129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression and regulation of Met and Ron proto-oncogenes in human hepatocellular carcinoma tissues and cell lines.
    Chen Q; Seol DW; Carr B; Zarnegar R
    Hepatology; 1997 Jul; 26(1):59-66. PubMed ID: 9214452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor.
    Santoro MM; Penengo L; Minetto M; Orecchia S; Cilli M; Gaudino G
    Oncogene; 1998 Aug; 17(6):741-9. PubMed ID: 9715276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis.
    Peace BE; Hughes MJ; Degen SJ; Waltz SE
    Oncogene; 2001 Sep; 20(43):6142-51. PubMed ID: 11593422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between RON receptor tyrosine kinase and other transmembrane receptors.
    Danilkovitch-Miagkova A; Leonard EJ
    Histol Histopathol; 2001 Apr; 16(2):623-31. PubMed ID: 11332718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM
    EXS; 1993; 65():131-65. PubMed ID: 8380735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the wild-type and Y1235D mutant Met kinase activation.
    Cristiani C; Rusconi L; Perego R; Schiering N; Kalisz HM; Knapp S; Isacchi A
    Biochemistry; 2005 Nov; 44(43):14110-9. PubMed ID: 16245927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between the receptor tyrosine kinases Ron and epidermal growth factor receptor.
    Peace BE; Hill KJ; Degen SJ; Waltz SE
    Exp Cell Res; 2003 Oct; 289(2):317-25. PubMed ID: 14499632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between scatter factor receptors and B plexins controls invasive growth.
    Conrotto P; Corso S; Gamberini S; Comoglio PM; Giordano S
    Oncogene; 2004 Jul; 23(30):5131-7. PubMed ID: 15184888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
    Castro NE; Lange CA
    Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen-related growth factor and semaphorin receptors: a gene superfamily controlling invasive growth.
    Comoglio PM; Tamagnone L; Boccaccio C
    Exp Cell Res; 1999 Nov; 253(1):88-99. PubMed ID: 10579914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients.
    Lee WY; Chen HH; Chow NH; Su WC; Lin PW; Guo HR
    Clin Cancer Res; 2005 Mar; 11(6):2222-8. PubMed ID: 15788670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma.
    Vanderwerff BR; Church KJ; Kawas LH; Harding JW
    Cytokine; 2019 Nov; 123():154762. PubMed ID: 31254927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor and macrophage-stimulating protein are upregulated during excisional wound repair in rats.
    Cowin AJ; Kallincos N; Hatzirodos N; Robertson JG; Pickering KJ; Couper J; Belford DA
    Cell Tissue Res; 2001 Nov; 306(2):239-50. PubMed ID: 11702235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scatter factor receptors are key players in a unique multistep program leading to invasive growth.
    Bardelli A; Comoglio PM
    Ciba Found Symp; 1997; 212():133-44; discussion 144-7. PubMed ID: 9524768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.